Literature DB >> 16996479

Subproteomic study of hepatitis C virus replicon reveals Ras-GTPase-activating protein binding protein 1 as potential HCV RC component.

Zhigang Yi1, Caiyun Fang, Tingting Pan, Jiadong Wang, Pengyuan Yang, Zhenghong Yuan.   

Abstract

Hepatitis C virus (HCV) RNA synthesis takes place on a detergent resistant membrane (DRM) structure. To identify potential cellular proteins related to HCV replication complexes (RC), we purified DRMs from HCV subgenomic replicon cells and its parental Huh7 cells. The proteins of DRM fractions were separated by two-dimensional gel electrophoresis and identified by mass spectrometry. Comparing with parental Huh7 cells, 60 proteins were up-regulated while 14 proteins were down-regulated in HCV replicon cells. Ras-GTPase-activating protein binding protein 1 (G3BP1), one of the elevated proteins, was found to be associated with HCV NS5B and knockdown of G3BP1 by siRNA in HCV replicon cells significantly reduced HCV replication, which may indicate it a potential component of HCV RC. These results suggest that HCV viral gene and proteins may regulate the presence of host cellular proteins in DRM, ensure appropriate concentrations of replication components, and hence control the rates or efficiencies of HCV replication.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16996479     DOI: 10.1016/j.bbrc.2006.09.027

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Host factors associated with the Sindbis virus RNA-dependent RNA polymerase: role for G3BP1 and G3BP2 in virus replication.

Authors:  Ileana M Cristea; Heather Rozjabek; Kelly R Molloy; Sophiya Karki; Laura L White; Charles M Rice; Michael P Rout; Brian T Chait; Margaret R MacDonald
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

2.  Hepatitis C virus co-opts Ras-GTPase-activating protein-binding protein 1 for its genome replication.

Authors:  Zhigang Yi; Tingting Pan; Xianfang Wu; Wuhui Song; Shanshan Wang; Yan Xu; Charles M Rice; Margaret R Macdonald; Zhenghong Yuan
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

3.  Modulation of hepatitis C virus RNA abundance and virus release by dispersion of processing bodies and enrichment of stress granules.

Authors:  Cara T Pager; Sylvia Schütz; Teresa M Abraham; Guangxiang Luo; Peter Sarnow
Journal:  Virology       Date:  2012-11-09       Impact factor: 3.616

Review 4.  Proteomic approaches to analyzing hepatitis C virus biology.

Authors:  Florian Douam; Alexander Ploss
Journal:  Proteomics       Date:  2015-05-05       Impact factor: 3.984

5.  Hepatitis C virus hijacks P-body and stress granule components around lipid droplets.

Authors:  Yasuo Ariumi; Misao Kuroki; Yukihiro Kushima; Kanae Osugi; Makoto Hijikata; Masatoshi Maki; Masanori Ikeda; Nobuyuki Kato
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

6.  Stress Granules and Virus Replication.

Authors:  Cathy L Miller
Journal:  Future Virol       Date:  2011       Impact factor: 1.831

7.  Hepatitis C virus-related hepatocellular carcinoma: An insight into molecular mechanisms and therapeutic strategies.

Authors:  Denis Selimovic; Abdelouahid El-Khattouti; Hanan Ghozlan; Youssef Haikel; Ola Abdelkader; Mohamed Hassan
Journal:  World J Hepatol       Date:  2012-12-27

8.  Involvement of creatine kinase B in hepatitis C virus genome replication through interaction with the viral NS4A protein.

Authors:  Hiromichi Hara; Hideki Aizaki; Mami Matsuda; Fumiko Shinkai-Ouchi; Yasushi Inoue; Kyoko Murakami; Ikuo Shoji; Hayato Kawakami; Yoshiharu Matsuura; Michael M C Lai; Tatsuo Miyamura; Takaji Wakita; Tetsuro Suzuki
Journal:  J Virol       Date:  2009-03-04       Impact factor: 5.103

9.  A host YB-1 ribonucleoprotein complex is hijacked by hepatitis C virus for the control of NS3-dependent particle production.

Authors:  Laurent Chatel-Chaix; Marie-Anne Germain; Alena Motorina; Éric Bonneil; Pierre Thibault; Martin Baril; Daniel Lamarre
Journal:  J Virol       Date:  2013-08-28       Impact factor: 5.103

Review 10.  New targets for treatment against HCV infection.

Authors:  Qiuwei Pan; Luc J W van der Laan
Journal:  Best Pract Res Clin Gastroenterol       Date:  2012-08       Impact factor: 3.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.